SMMT

Summit Therapeutics Inc · NASDAQ

Sector Health Technology
Industry Biotechnology
Website ummittxinc.com
Employees(FY) 76
ISIN US86627T1088

Performance

0.0%

-10.65%

-22.84%

+125.06%

+584.67%

YTD

+636.91%

Profile

Summit Therapeutics Inc., a biopharmaceutical company, research and develops primarily oncology therapies in the United States, and the United Kingdom. The company's product pipeline includes SMT-738, a novel class of precision antibiotics for treatment which is in preclinical stage for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. It has a collaboration and license agreement with Akeso, Inc. for research and develop Ivonescimab (AK112) and SMT112, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis. The company was founded in 2003 and is headquartered in Cambridge, Massachusetts.

Advanced Technical Analysis

Technical Analysis of SMMT 2024-12-20

The stock indicators reflect a bearish sentiment, with the Moving Average Score at 30, the Oscillators Score at 46, and the overall Technical Score at 38, suggesting a lack of upward momentum and potential weakness in the stock's performance. This combination indicates that caution may be warranted for investors considering this stock.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of SMMT

Stock Rank

Recent News & Updates

2024-12-20 06:30
Where Will Summit Therapeutics Be in 5 Years?(Motley Fool)
2024-12-20 04:50
3 Stocks That Could Turn $1,000 into $5,000 by 2030(Motley Fool)
2024-12-18 05:44
3 No-Brainer Biotech Stocks to Buy With $200 Right Now(Motley Fool)
2024-12-15 07:37
2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street(Motley Fool)
2024-12-14 16:00
Investing $5,000 in Each of These 3 Stocks at the Start of 2024 Would Have Created a Portfolio Worth More Than $100,000 Today(Motley Fool)
2024-12-13 16:15
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Business Wire)
2024-12-13 03:15
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Businesswire)
2024-12-11 08:26
Wells Fargo Initiates Summit Therapeutics at Overweight With $30 Price Target(MT Newswires)
2024-12-09 08:13
Here's Why Summit Therapeutics Stock Price Rose 6% on Friday(Zacks)
2024-12-06 19:09
Why Summit Therapeutics Stock Rocketed 6% Higher on Friday(Motley Fool)
2024-12-06 08:56
Jefferies Initiates Summit Therapeutics at Buy With $31 Price Target(MT Newswires)
2024-12-02 04:22
Billionaire Ken Griffin Is Selling Palantir and Buying a Stock Wall Street Expects to Rocket 139% Higher(Motley Fool)
2024-11-30 06:05
Warning: This Skyrocketing Stock Has a Hidden Risk(Motley Fool)
2024-11-26 16:15
Summit Therapeutics to Present at Upcoming Investor Conferences(Business Wire)
2024-11-26 03:15
Summit Therapeutics to Present at Upcoming Investor Conferences(Businesswire)
2024-11-23 06:30
3 Monster Stocks in the Making(Motley Fool)
2024-11-21 16:15
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Business Wire)
2024-11-21 03:15
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Businesswire)
2024-11-20 08:27
Summit Therapeutics (SMMT) Hurt Bronte Capital. Here’s Why(Insider Monkey)
2024-11-14 10:32
Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics(Investor's Business Daily)
2024-11-10 18:26
TipRanks’ ‘Perfect 10’ Picks: 2 Top-Scoring Stocks for the Rest of 2024(TipRanks)
2024-11-08 07:00
2 Hot Biopharma Stocks to Buy and Hold for 5 Years(Motley Fool)
2024-11-04 18:56
Why Summit Therapeutics Stock Was a Winner Today(Motley Fool)
2024-11-04 14:14
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo(Benzinga)
2024-11-04 13:43
Summit Therapeutics Leads the Parade of Big Gainers(GuruFocus.com)
2024-11-03 06:41
3 Magnificent Stocks Under $100 to Buy in November(Motley Fool)
2024-10-31 08:42
Summit Therapeutics Posts Wider-Than-Expected Loss in Q3, Nil Sales(Zacks)
2024-10-31 08:29
3 Stocks That Have Generated 1,000% Returns in Just 2 Years(Motley Fool)
2024-10-31 07:01
Summit Therapeutics Inc (SMMT) Q3 2024 Earnings Call Highlights: Strategic Advances and ...(GuruFocus.com)
2024-10-31 01:06
Decoding Summit Therapeutics Inc (SMMT): A Strategic SWOT Insight(GuruFocus.com)

Page 1 of 10

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.